Health benefits of magic mushroom spores

Psilocybin “magic mushroom spores”: Relief for Depression & Anxiety After One Dose?

While magic mushroom spores and hallucinogens seem like relics from a hippie, Grateful Dead–loving past, they’re giving doctors new hope in treating a range of mental health issues.

In particular, the “magic mushrooms” discussed here contain psilocybin, which a recent study indicated could help alleviate severe depression. Previously, studies have also indicated that psilocybin can reduce anxiety and depression among cancer patients.

click here to buy magic mushrooms in the uk

However, psilocybin is also labeled a Schedule I substance under the Controlled Substances Act, according to the U.S. Department of Justice.

Therein lies the rub. Let’s take a look at what the research indicates regarding its therapeutic potential and the complicated legal picture.

What Is magic mushroom spores?

magic mushroom spores are known as Psilocybe cubensis and are a species of psychedelic mushrooms. They’re the scientific name for more than 100 mushroom species that contain psilocybin and psilocin. These two compounds account for the psychoactive properties that cause hallucinations and “tripping” when a person ingests these mushrooms.

magic mushroom spores

These so-called magic mushroom spores can be wild or cultivated. Psilocybin is also considered a popular but illegal psychedelic, according to the Substance Abuse and Mental Health Services Administrations.

magic mushroom spores with psilocybin are often prepared by drying and then are ingested, often by being mixed into food or drinks. They also go by such names as shrooms, booms, golden tops, blue meanies and mushies.

The effects of psilocybin usually take around 30 minutes to start and can last up to six hours.

Like most drugs and chemicals that alter the mind, researchers aren’t yet exactly sure psilocybin works. What they do know, however, is that when psilocybin reaches the brain, it decreases brain activity, particularly in the medial prefrontal cortex (mPFC) and the posterior cingulate cortex (PCC). The mPFC is associated with obsessive thinking and, in people with depression, is usually overactive. In fact, antidepressants all stifle mPFC.

The PCC, on the other hand, is believed to play a role in consciousness, ego and sense of self. Psilocybin seems to quiet down the “noise” in a person’s brain, letting that person access parts of the mind that are normally stifled. It also seems to affect serotonin, the neurotransmitter linked to moods, anxiety and depression.

One researcher likened psilocybin to “inverse PTSD.” But instead of a traumatizing incident haunting patients, the magic mushroom spores creates a really positive memory they can turn to for months. It also shows promise in helping curb the reliance on pharmaceutical drugs in certain instances.

In fact, during the 1950s and ’60s, hallucinogens like psilocybin were being studied for their potential in the psychiatry and oncology fields. However, in 1970, the Controlled Substances Act was signed into law. It categorized hallucinogens like psilocybin mushrooms as a Schedule 1 drug, meaning it has a high potential for abuse and had no accepted medical use in treatment in the U.S. Federal funds for research dried up.

But slowly the tide is turning, as the latest studies about psilocybin show there is a lot of therapeutic potential to be explored.

Potential Benefits of magic mushroom spores

The latest research is indicating that psilocybin may assist with serious medical conditions, and research institutions like Johns Hopkins University are urging a reclassification of this substance from Schedule I to IV so it can be used for medical treatments. In fact, Johns Hopkins operates the Center for Psychedelic and Consciousness Research, where researchers focus on how psychedelics affect behavior, mood, cognition, brain function and the biological markers of health.

In any case, if such a shift to Schedule IV were to happen, psilocybin would be available by a prescription. Here are some of the promising benefits of psilocybin mushrooms.

1. Depression  

In a groundbreaking new study published in the New England Journal of Medicine, a single dose of a synthetic version of magic mushroom spores helped alleviate depression in people with a treatment-resistant version of the disease. Treatment-resistant depression can only be diagnosed if a person doesn’t respond to two separate courses of antidepressants, and it can be fairly common — of the 9 million Americans who have medically treated depression, 3 million are considered treatment-resistant.

magic mushroom spores

The randomized, double-blind clinical trial with 233 participants compared results of a 25-milligram dose to a 10-milligram and 1-milligram dose. The strongest dose of 25 milligrams was far more effective than the other doses and the effects lasted up to three months.

Depression levels were evaluated the day after the does and then another five times over a three-month period. Around 37 percent of participants who took the 25-milligram dose showed improvement and 29 percent were shown to be in remission at week three.

However, adverse events occurred in 77 percent of the participants, a high-risk group. This included headache, nausea and dizziness after the dose day. In addition, suicidal ideation or behavior or self-injury occurred with some individuals in all three dose groups.

Therefore, trials that are both larger and longer will be needed to determine how effective and safe psilocybin is for treatment-resistant depression.

2. Depression and anxiety among cancer patients

For people with cancer, the diagnosis often is just the beginning. The side effects from a variety of treatments, the anxiety that comes along with a life-threatening illness, having to navigate the regular stresses of daily life — it can be a lot to handle. In fact, it’s estimated that more than 30 percent of cancer patients meet the criteria for mood disorders.

The threat isn’t over after eliminating the disease, either. Suicide rates among cancer survivors is nearly double that of the general population. Could magic mushroom spores change that?

Two studies published in the Journal of Psychopharmacology found that psilocybin reduces anxiety and depression among cancer patients and survivors in just one session. These one-off experiences also had lasting effects.

Just this single dose of psilocybin, which lasts between four to six hours, decreased anxiety and depression in most participants and occurred right in that session, as opposed to antidepressants and therapy, which can take weeks or months to work. Participants found themselves with an increased quality of life, life meaning and optimism.

The results were long-lasting, too. Six months after the last treatment, 80 percent of the group continued showing clinically significant decreases in depressed mood and anxiety. Eighty-three percent said there was an increase in their well-being, and 67 percent rated the experience as one of the top five meaningful experiences in their lives.

3. Cluster headaches

Another study discovered that people who self-medicated (again, this is illegal in the U.S.) with small doses of psilocybin were able to alleviate cluster headaches while avoiding any psychoactive effects of the drug. This so-called microdosing may allow the benefits of the substance to be experience while greatly minimizing the undesirable side effects.

Future Studies and Side Effects on magic mushroom spores 

oyster mushrooms

Will magic mushroom spores become the new go-to treatment for depression and potentially other disorders like anorexia or bulimia? Not so fast.

For starters, these studies required a waiver in order to use psilocybin, as it’s still illegal in the U.S. Additionally, these studies were conducted with professionals in a controlled, supervised environment.

The participants were screened for family histories of mental illness and other drug use. For certain mental diseases, like schizophrenia, treatment with psilocybin would likely be harmful. The researchers involved in the study also emphasized that the positive results doesn’t mean that people should hallucinogenic mushrooms in a treatment plan.

In addition, side effects from using psilocybin mushrooms can include nausea, fatigue, nervousness, paranoia, hallucinations, panic and even psychosis.

Final Thoughts on magic mushroom spores 

magic mushroom spores is an exciting, promising therapy for people dealing with devastating depression and other maladies. Johns Hopkins is also studying its application for quitting smoking, Alzheimer’s, Lyme Disease, obsessive compulsive disorder and eating disorders.

But because it’s not likely to become a widespread therapy anytime soon, it’s not a treatment you can really bank on. If you are interested, keep your eyes peeled for trials. And if you are feeling depressed, anxious or suicidal, please get in touch with your health provider and/or the National Suicide Prevention Hotline.

Frequent ask question on magic mushroom spores

1. What are the health benefits of magic mushroom spores?

Magic mushrooms, containing psilocybin, can offer health benefits like helping people quit smoking, treating addiction to alcohol, and easing depression in those who have not found relief with standard treatments.

2. Can psychedelic therapy with magic mushrooms help mental health issues?

Yes! Psychedelic therapy using psilocybin from magic mushrooms is being studied for its potential to treat various psychiatric illnesses such as treatment-resistant depression and obsessive-compulsive disorder.

3. Are there risks of taking magic mushroom spores?

Like any substance affecting the brain, there are risks including bad trips that can make a person feel anxious or fearful; misuse may lead to drug abuse or aggravate conditions like psychosis or bipolar disorder.

4. How do magic mushroom spores work as medication?

The active compound in magic mushrooms acts on serotonin receptors in the brain which could ease conditions like depression; it’s why researchers at places like COMPASS Pathways and Heffter Research Institute focus on their psychotherapeutic potential.

5. Is it legal to use psilocybin from magic mushroom spores for treatment?

Legality varies: some areas are moving to decriminalize psilocybin while others still consider it illegal; however clinical trials under strict supervision are conducted as part of research into its medical uses.

6. Can someone with a terminal illness benefit from taking psychedelic drugs like psilocybin?

Yes, terminally ill patients may find relief from distressing symptoms by using serotonergic psychedelics under psychotherapeutic guidance—it might help reduce anxiety and improve behavioral health during difficult times.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
error: Content is protected !!